← All companies
Axsome Therapeutics, Inc.
AXSM - CIK 0001579428
Market cap$13.13 B
Rank#799
SEC filings634
The table below shows Axsome Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $305.11M | $325.27M | $303.02M | $300.91M | $327.34M | $315.66M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $251.06M | $196.51M | $198.82M | $161.40M | $124.10M | $120.34M |
| Inventory | $31.52M | $23.77M | $18.44M | $16.32M | $14.27M | $15.22M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.